Stay updated on Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial
Sign up to get notified when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.

Latest updates to the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page
- Check6 days agoChange DetectedThe page now lists 44 locations for the study; the detailed site list has been trimmed. Revision: v3.5.0 is displayed on the page.SummaryDifference4%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedVersion update: added Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedVersion label updated from v3.4.1 to v3.4.2 in the page footer.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded a Lancet HIV 2021 96-week results publication citation with revision note (v3.4.1) and removed the Lancet HIV erratum reference with revision (v3.4.0).SummaryDifference0.0%

- Check57 days agoChange DetectedUI/metadata updates were applied: a Show glossary option was added, and the page now displays a Last Update Submitted that Met QC Criteria field along with a Revision indicator (v3.4.0). The older QC Criteria label (Last Update Submitted that met QC Criteria) and the No FEAR Act data label were removed, and capitalization of FEAR Act data was adjusted.SummaryDifference0.1%

- Check64 days agoChange DetectedA new 'Last Update Posted' field was added to the Study Details page. The 'Last Update Posted (Estimated)' field was removed.SummaryDifference0.0%

Stay in the know with updates to Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.